Medicare Part D Drug Prices

Investors Warned At Morgan Stanley Dinner About Stealth Drug Price Controls

Watch out for government to take a “back door” approach to stealth drug price controls. Such was the topic recently discussed at a Morgan Stanley dinner and put in report form, which was reviewed by ValueWalk. Political rancor regarding a single payer system or overt price controls are likely to be a smokescreen to pressure the back door solution, those attending the March 23 dinner were told. Plus there is the “threat” of a little known payment committee, the “death panel,” that could come into play. The report . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 11/30/2019 or after next 25 12 subscribers take advantage whichever comes first – please do not share this discount with others

 

0